[1]   Recent progress concerning CpG DNA and its use as a vaccine adjuvant
Expert review of vaccines 2014

[2]   Targeting myeloid cells using nanoparticles to improve cancer immunotherapy
Advanced drug delivery reviews, Elsevier 2014

[3]   The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy
Cancer gene therapy 2015

[4]   Enhancement of anti-tumor effect of particulate vaccine delivery system by'bacteriomimetic'CpG functionalization of poly-lactic-co-glycolic acid nanoparticles
Nanomedicine 2015

[5]   Modulation of Dendritic Cells by Nanotechnology-Based Immunotherapeutic Strategies
Journal of Biomedical Nanotechnology 2016

[6]   Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2016

[7]   Formulation, characterization and validation of CpG functionalized PLGA bacteriomimetic nanoparticles for breast cancer immunotherapy
2015

[8]   DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Pharmacology & Therapeutics 2016

[9]   The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape …
Cancer Gene Therapy 2015

[10]   CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
International journal of nanomedicine 2017

[11]   靶向免疫系统的递药系统研究进展
中国药科大学学报 2015

[12]   The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape …
Cancer Gene Therapy 2015

[13]   Polymeric Immunonanoparticles Mediated Cancer Therapy: A Versatile Nanocarriers for Cell Specific Cargo Delivery
2017

[14]   Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic'CpG functionalization of poly-lactic-co-glycolic acid nanoparticles
2015

[15]   Aptamer-mediated polymeric vehicles for enhanced cell-targeted drug delivery
Current Drug Targets 2018

[16]   Polymeric Immunonanoparticles Mediated Cancer Therapy: Versatile Nanocarriers for Cell-Specific Cargo Delivery
2018

[17]   Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect
Immunology Letters 2018

[18]   Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences
Journal of Controlled Release 2018

[19]   Polymer nanoparticles as adjuvants in cancer immunotherapy
Nano Research 2018

[20]   Cationic polymers for enhancing CpG oligodeoxynucleotides-mediated cancer immunotherapy
2019